Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TLSI
#3331
TriSalus Life Sciences, Inc. - Common Stock
4.8
3
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.03%
Monthly Change
+6.15%
6 month change
-3.40%
Year Change
-7.65%
Previous Close
4.9
3
Open
4.8
3
Low
4.8
3
High
4.8
3
Volume
35
Markets
US Stock Market
Healthcare
Medical Devices
TLSI
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Quarterly report, Q2 FY2024
2024.08.14
Trisalus Life Sciences, Inc. quarterly report, Q2 FY2024
10-Q
Current report, Q2 FY2024
2024.06.27
Trisalus Life Sciences, Inc. current report, Q2 FY2024
8-K
1
2
3
4
5
News
Wasatch Micro Cap Fund Q2 2026 Contributors And Detractors
QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last?
TriSalus Life Sciences, Inc. (TLSI) Q1 2026 Earnings Call Transcript
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
VAREX IMAGING (VREX) Q2 Earnings and Revenues Miss Estimates
Jones Trading reiterates Buy on TriSalus Life Sciences stock after earnings
TriSalus Life Sciences, Inc. (TLSI) Q4 2025 Earnings Call Transcript
Earnings call transcript: TriSalus Life Sciences sees 60% Q4 revenue rise
TriSalus prices $40M public offering at $4.10 per share
TriSalus Life Sciences appoints Michael Stansky to board of directors
TriSalus Life Sciences, Inc. (TLSI) Upgraded to Buy: Here's What You Should Know
TriSalus Life Sciences reports 60% revenue growth in Q4 2025